New gene mutations found in white blood cells in patients with rheumatoid arthritis

June 21, 2017, University of Helsinki
Scanning electron micrograph of a human T lymphocyte (also called a T cell) from the immune system of a healthy donor. Credit: NIAID

Gene mutations accumulating in cells are typical of the development of cancer. Finnish researchers have found that a similar accumulation of mutations occurs also in some patients with rheumatoid arthritis.

Gene mutations that accumulate in somatic have a significant impact on the development of cancer, yet no studies on their involvement in the pathogenesis of have previously been conducted. A research project conducted in cooperation by the University of Helsinki and the Helsinki University Central Hospital found that somatic mutations were present also in patients with .

Published in the Nature Communications journal, the study found mutations in genes important to the immune defence system in white cells separated from blood samples taken from patients recently diagnosed with rheumatoid arthritis.

"It may be possible that these mutations affect the regulation of the inflammatory process," says Satu Mustjoki, a research professor at the Finnish Cancer Institute and the University of Helsinki.

Altogether, 85 patients with recently diagnosed rheumatoid arthritis participated in the study, in addition to which there were 20 healthy control subjects. By utilising the latest deep sequencing techniques, the researchers identified mutations in one-fifth of the patients. All identified mutations were located in cells known as killer cells, or cytotoxic CD8+ T cells. No mutations were found in , or CD4+ T cells.

"One somatic mutation was found in a single healthy control subject, which means that the finding is not entirely arthritis specific," notes Professor Marjatta Leirisalo-Repo, a specialist in rheumatology.

Mutations only develop in mature T cells

The ability found in T cells to recognise countless protein structures inherent in pathogens is based on their versatile selection of T cell receptors. This selection is formed in the thymus, where gene stubs that code the T cell receptors found in T cells are split and rearranged into functioning receptors. Thus, the surface of each new T cell is imbued with a unique T cell receptor.

When the immune defence system is activated, T cells multiply exponentially while identical T cells form cell clones that can be identified by the rearrangement of their shared, unique T cell receptor.

Enlarged T cell clones were found in all patients with rheumatoid arthritis concomitant with somatic mutations. Further investigation proved that the mutations were limited to these enlarged cell clones.

"This indicates that mutations are formed only in mature T cells, not at the stem cell level," say BM Paula Savola and PhD Tiina Kelkka, the main authors of the article. "If mutations were formed at the earlier differentiation stage, they would have been present in CD8+ T cells and CD4+ helper cells expressing other T cell receptor types as well."

The mutations were found to be permanent, since identical clones and mutations were found in the patients' several years after the original finding.

Are mutations "genomic scars?"

"For now, there is no certainty on how these mutations affect the regulation of chronic inflammations. They may be, for lack of a better word, 'genomic scars' formed as a result of the activation of the system," says Mustjoki.

"In any case, this research project revealed a new connection on the molecular level between autoimmune diseases and cancer, which brings us one step closer to understanding these diseases."

The starting point for this project was earlier findings related to LGL leukaemia made by Mustjoki's research group. In LGL leukaemia, often found in the STAT3 gene and located also in the cytotoxic T cells of patients cause a slowly progressing blood disorder, in addition to which they predispose to autoimmune diseases. The most common autoimmune disease related to LGL leukaemia is rheumatoid arthritis.

"In the future, we intend to study the prevalence of this phenomenon in other inflammatory conditions and the practical significance of these as regulators of inflammatory reactions," says Mustjoki.

Explore further: Scientists identify single-gene mutations that lead to atopic dermatitis

More information: Somatic mutations in clonally expanded cytotoxic T lymphocytes in patients with newly diagnosed rheumatoid arthritis. Nature Communications. DOI: 10.1038/ncomms15869

Related Stories

Scientists identify single-gene mutations that lead to atopic dermatitis

June 19, 2017
Researchers have identified mutations in a gene called CARD11 that lead to atopic dermatitis, or eczema, an allergic skin disease. Scientists from the National Institute of Allergy and Infectious Diseases (NIAID), part of ...

Mutations unveiled that predispose lung cancers to refractory histologic transformation

June 7, 2017
Cancer pedigree analysis reveals the mutations in RB1 and TP53 genes play a key role in treatment-resistant, cancer cell-type transformation during EGFR inhibitor therapy for lung cancers.

Finnish researchers identify the cause for LGL leukemia

May 16, 2012
Researchers of the University of Helsinki, Helsinki University Central Hospital and Institute for Molecular Medicine Finland, have discovered that a mutation in the STAT3 gene is an underlying cause for LGL leukemia. Since ...

First mutations in human life discovered: Archaeological traces of embryonic development seen in adult cells

March 22, 2017
The earliest mutations of human life have been observed by researchers at the Wellcome Trust Sanger Institute and their collaborators. Analysing genomes from adult cells, the scientists could look back in time to reveal how ...

Premature cell differentiation leads to disorders in pancreatic development

April 11, 2017
Researchers at the University of Helsinki, Finland, have uncovered a mechanism through which a mutation in the STAT3 gene leads to a disorder in the development of the pancreas and to infant diabetes.

New statistical analysis reveals thousands of rare mutations linked with cancer

April 20, 2017
Scientists have identified thousands of previously ignored genetic mutations that, although rare, likely contribute to cancer growth. The findings, which could help pave the way to new treatments, are published in PLOS Computational ...

Recommended for you

Researchers find potential new gene therapy for blinding disease

August 20, 2018
The last year has seen milestones in the gene therapy field, with FDA approvals to treat cancer and an inherited blinding disorder. New findings from a team led by University of Pennsylvania vision scientists, who have in ...

New study explains why genetic mutations cause disease in some people but not in others

August 20, 2018
Researchers at the New York Genome Center (NYGC) and Columbia University have uncovered a molecular mechanism behind one of biology's long-standing mysteries: why individuals carrying identical gene mutations for a disease ...

Critical role of DHA on foetal brain development revealed

August 17, 2018
Duke-NUS researchers have found evidence that a natural form of Docosahexaenoic Acid (DHA) made by the liver called Lyso-Phosphatidyl-Choline (LPC-DHA), is critical for normal foetal and infant brain development, and that ...

New algorithm could improve diagnosis of rare diseases

August 17, 2018
Today, diagnosing rare genetic diseases requires a slow process of educated guesswork. Gill Bejerano, Ph.D., associate professor of developmental biology and of computer science at Stanford, is working to speed it up.

Gene silencing critical for normal breast development

August 17, 2018
Researchers have discovered that normal breast development relies on a genetic 'brake', a protein complex that keeps swathes of genes silenced.

Officials remove special rules for gene therapy experiments

August 16, 2018
U.S. health officials are eliminating special regulations for gene therapy experiments, saying that what was once exotic science is quickly becoming an established form of medical care with no extraordinary risks.

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.